---
title: "Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates | SER Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286462168.md"
description: "Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates | SER Stock News"
datetime: "2026-05-14T12:20:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286462168.md)
  - [en](https://longbridge.com/en/news/286462168.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286462168.md)
---

# Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates | SER Stock News

Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates | SER Stock News

### Related Stocks

- [SER.US](https://longbridge.com/en/quote/SER.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Capricor publishes investor presentation on deramiocel Duchenne muscular dystrophy program](https://longbridge.com/en/news/287222906.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Neurothera Labs Announces Adoption of Semi-Annual Reporting](https://longbridge.com/en/news/287119698.md)
- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)